Psilocybin: promising results in double-blind trials require confirmation by real-world evidence Read More > December 6, 2016
Psilocybin-assisted psychotherapy for dying cancer patients – aiding the final trip Read More > December 6, 2016
Psilocybin for depression and anxiety associated with life-threatening illnesses Read More > December 6, 2016
Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder Read More > December 6, 2016
Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies Read More > December 5, 2016
Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration Read More > December 2, 2016
The role of psychedelics in palliative care reconsidered: A case for psilocybin Read More > December 1, 2016
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology Read More > December 1, 2016
